Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Anti Microbial Peptides Market Forecast: Value Set To Climb From $7.62 Billion To $10.39 Billion
The antimicrobial peptides market size has observed substantial growth in recent years. It is forecast to increase from $7.03 billion in 2025 to $7.62 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.4%. This expansion during the preceding period can be linked to escalating concerns regarding antimicrobial resistance, academic studies on innate immunity peptides, early-phase clinical investigations, augmented funding for substitute antimicrobials, and improvements in peptide synthesis capabilities.
The antimicrobial peptides market is expected to witness significant expansion over the next few years. Its valuation is projected to reach $10.4 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.1%. This anticipated growth during the forecast period is fueled by the increasing commercialization of AMP-based therapeutics, their growing application in antiviral and antifungal treatments, the expansion of their use in agricultural and veterinary sectors, rising investment in peptide drug platforms, and increasing regulatory support for novel antimicrobials. Key trends identified for the forecast period include increasing research into antibiotic alternatives, the rising development of broad-spectrum AMPs, the expansion of clinical applications beyond bacterial infections, a growing focus on resistance-resilient therapies, and enhanced peptide engineering techniques.
Get A Free Sample Report With In-Depth Market Insights:
Anti Microbial Peptides Market Industry Drivers: What’s Behind The Revenue Growth?
The escalating occurrence of infectious diseases is anticipated to boost the antimicrobial peptide market moving forward. Infectious diseases describe conditions resulting from detrimental organisms such as bacteria, viruses, fungi, or parasites. The increasing prevalence of infectious diseases can be linked to factors like climate shifts, the emergence of drug-resistant pathogens, and unhealthy eating habits. Antimicrobial peptides present a promising method for combating infectious diseases by offering new therapeutic choices that address the expanding issue of antibiotic resistance and the limitations of conventional therapies. For instance, in February 2025, according to Gov.UK, a UK-based public sector information website, HIV diagnoses in England totaled 2,451 in 2022, subsequently rising by 15% to 2,810 in 2023. Thus, the growing incidence of infectious diseases acts as a primary driver for the antimicrobial peptide market.
Anti Microbial Peptides Market Segment Analysis: What Are The Core Market Categories?
The anti microbial peptides market covered in this report is segmented –
1) By Type: Plant Antimicrobial Peptides, Bacterial Antimicrobial Peptides, Animal Antimicrobial Peptides, Insect Antimicrobial Peptides
2) By Ailments: Pneumonia, Hepatitis, Bacterial infections, Human Immunodeficiency Viruses
3) By Route of Administration: Topical, Subcutaneous, Intravenous
4) By Distribution Channel: Hospital, Research Institutes, Specialty Clinic, Pharmacies
5) By End-User: Pharma And Healthcare, Agriculture Industry, Biological Engineering
Subsegments:
1) By Plant Antimicrobial Peptides: Defensins, Thionins, Hevein-Like Peptides, Plant Defensin-Like Peptides, Lipid Transfer Proteins (LTPs)
2) By Bacterial Antimicrobial Peptides: Bacitracin, Nisin, Magainins, Protegrins, Bacillocins
3) By Animal Antimicrobial Peptides: Cathelicidins, Defensins, Histatins, Lactoferrin, Cationic Antimicrobial Peptides (CAMPs)
4) By Insect Antimicrobial Peptides: Cecropins, Defensins, Attacins, Diptericins, Melittin
#Anti Microbial Peptides Market Growth Trends: What’s Shaping The Future Outlook?
Major companies in the anti-microbial peptides market are actively developing cutting-edge products, such as biodegradable antimicrobial peptides, to counter emerging antimicrobial resistance challenges and improve treatment efficacy. Biodegradable antimicrobial peptides are short proteins capable of naturally breaking down into harmless substances after performing their function of neutralizing or inhibiting harmful microorganisms like bacteria, viruses, and fungi. For instance, in September 2024, Beiersdorf AG, a Germany-based company known for manufacturing personal care products, entered into a partnership with Macro Biologics, a US-based bioengineering company, to advance the development of antimicrobial peptides. This collaboration is dedicated to creating innovative solutions using biodegradable antimicrobial peptides, highlighting a growing trend in the cosmetics industry to adopt advanced biotechnological innovations for both performance and sustainability objectives.
Anti Microbial Peptides Market Top Companies Driving Competitive Growth
Major companies operating in the anti microbial peptides market are Wuxi AppTec, Sigma Aldrich Chemicals Private Limited, Ipsen S.A., Novozymes A/S, GenScript Biotech, Bachem Holding AG, Basilea Pharmaceutica Ltd., Probiotec Limited, Migenix Inc., Zymeworks Inc., Venatorx Pharmaceuticals Inc., AMPS Biotech Pvt. Ltd., AnaSpec Inc., MediGene AG, Hycult Biotech, Phoenix Biotechnology Inc., Shenzhen Sunsmile Biotechnology Co. Ltd., WatsonBio Sciences, Helix BioMedix, Jiangsu ProteLight Pharmaceutical and Biotechnology Co Ltd.
View The Full Anti Microbial Peptides Market Report:
Anti Microbial Peptides Market Regional Outlook: Where Is Opportunity Concentrated?
North America was the largest region in the anti-microbial Peptides market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti microbial peptides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model